Melanoma

1. Acral Melanoma

   • Toshiaki Saida

2. Adjuvant Therapy

   • Diwakar Davar, John M. Kirkwood

3. Animal Models of Melanoma

   • Zackie Aktary, Martin McMahon, Lionel Larue

4. Artificial Intelligence Approach in Melanoma

   • Clara Curiel-Lewandrowski, Roberto A. Novoa, Elizabeth Berry, M. Emre Celebi, Noel Codella, Felipe Giuste et al.

5. Biology of Melanoma Metastasis

   • Qiaoli Ma, Lothar C. Dieterich, Michael Detmar

6. Clinical Management of Primary Cutaneous Melanoma

   • Sonia Cohen, Kenneth Tanabe

7. Combinatorial Approach to Treatment of Melanoma

   • Kamran Abri, Adil I. Daud

8. Congenital Melanocytic Naevi

   • Veronica A. Kinsler, Miguel Reyes-Mugica, Ashfaq Marghoob

9. Cutaneous Adverse Events of Systemic Melanoma Treatments

   • Christian Menzer, Steven T. Chen, Gregory S. Phillips, Mario E. Lacouture

10. Desmoplastic Melanoma

    • Teresa A. Bailey, John F. Thompson, Richard A. Scolyer

11. Developmental Biology of Melanocytes

    • Lukas Sommer

12. Epidemiology of Melanocytic Neoplasia

    • Margaret Anne Tucker

13. Epigenetic Regulation in Melanoma

    • Michelle Dang, Leonard Zon

14. Evolving Role of the Oncology Nurse in the Care of Patients with Melanoma

    • Krista M. Rubin

15. Genetic Counseling

    • Kelly Jo Hamman, Wendy Kohlmann, Sancy Leachman

16. Imaging Melanoma

    • Richard L. Wahl

17. Inherited Contributions to Melanoma Risk

    • Kevin M. Brown, Stuart MacGregor, Matthew H. Law

18. Key Signaling Pathways in Normal and Neoplastic Melanocytes

    • Andrew E. Aplin, Ashani T. Weeraratna

19. Management of Locally and Regionally Recurrent Melanoma

    • Cristina O’Donoghue, Jonathan S. Zager, Vernon K. Sondak

20. Melanoma Brain Metastasis: Insights, Progress, Challenges, and Opportunities

    • Grant M. Fischer, Michael A. Davies

Melanoma is a cutting edge, comprehensive reference work on the topic of melanoma. The overarching goal is to provide detailed scholarly information which broadly covers all aspects of the clinical presentation and management of the disease, as well as the biological and scientific understanding of its pathogenesis and treatment. Key topics highlighted include recent breakthroughs in molecular diagnostics, breakthroughs in targeted therapeutic approaches, overviews of signaling and transcriptional pathways, and important controversies such as screening, early diagnosis, sentinel node biopsy, and prevention strategies. In all, the volume provides a cutting edge and comprehensive presentation of the field of melanoma, written by a team of internationally renowned thought-leaders.

• Melanoma
• Oncology
• Skin Cancer
• Melanocytic Neoplasm
• Clinical Management

• Harvard/MGH Cutaneous Biology Research C Massachusetts General Hospital, Boston, USA

  David E. Fisher

• Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA

  Boris C. Bastian

David E. Fisher is a researcher, clinician and academic, and serves as Chief of the MGH Department of Dermatology, Director of the MGH Cutaneous Biology Research Center and Director of the Melanoma Center at MGH.  He is also  the President of the Society for Melanoma Research, the largest international society dedicated to the study of melanoma.  A professor of Pediatrics at Harvard Medical School, Fisher came to the MGH from the Dana-Farber Cancer Institute (DFCI), where he directed the Melanoma Program.

His research has focused on the molecular mechanisms of melanocyte biology; specifically, the developmental, signaling and transcriptional pathways responsible for human melanomas, hyperpigmentation, albinism and hair graying. Most recently, his work at the DFCI identified the transcription factor, Mitf, as essential for the development of normal melanocytes as well as responsible for cancerous transformations. As a clinician, he has worked to translate these new understandings into advances in diagnosis, treatment and prevention of human diseases related to the skin and associated disorders.

A graduate of Swarthmore College with a degree in Biology and Chemistry, Fisher is also a concert cellist and received a degree from the Curtis Institute of Music in Philadelphia. After completing a doctoral degree at Rockefeller University, he began his medical training at Cornell University Medical College and his residency in Internal Medicine at the MGH. Following the completion of clinical fellowships in both adult and pediatric oncology at the Dana-Farber Cancer Institute and Children's Hospital Boston and his postdoctoral research at MIT's Center for Cancer Research, Fisher joined the DFCI staff.

Boris C. Bastian, MD,  graduated from Humboldt-Gymnasium in Solingen, Germany, in 1980. After receiving his medical degree from the University of Munich, Germany, in 1988, he completed his residency in dermatology at the University of Wurtzburg, Germany. In 1997, he began working at the UCSF Cancer Center. Then in 1999, he joined the UCSF faculty with appointments in both dermatology and pathology.

 

His interests and investigative work includes a variety of projects during his tenure with UCSF. He is very interested in understanding the genetic underpinnings of skin cancer with the goal to improve diagnosis, therapy and prevention.

 

Policies and ethics